ReviewEvidence-based complementary and alternative medicine : eCAM2013
Classification and clinical diagnosis of fibromyalgia syndrome: recommendations of recent evidence-based interdisciplinary guidelines.
Review in Evidence-based complementary and alternative medicine : eCAM, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.
- Validity of Algorithms for Identification of Individuals Suffering from Chronic Noncancer Pain in Administrative Databases: A Systematic Review.Pain medicine (Malden, Mass.) · 2020Pooled it
- Ingestion of a THC-Rich Cannabis Oil in People with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.Pain medicine (Malden, Mass.) · 2020Trial
- The effects of long- and short-term interdisciplinary treatment approaches in women with fibromyalgia: a randomized controlled trial.Rheumatology international · 2016Trial
- Longitudinal stability of data-driven fibromyalgia phenotypes across repeated clinical assessments.Pain reports · 2026Article
- Determinants of adherence and safety in fully autonomous home-based transcranial direct current stimulation for fibromyalgia.Frontiers in pain research (Lausanne, Switzerland) · 2026Article
- Fibromyalgia: do I tackle you with complementary medicines?Pain reports · 2025Review
- Analysis of malingered psychological symptoms in a clinical sample for early detection in initial interviews.European archives of psychiatry and clinical neuroscience · 2023Article
- A retrospective analysis of the prevalence and impact of associated comorbidities on fibromyalgia outcomes in a tertiary care center.Frontiers in medicine · 2023Article
- Refractory fibromyalgia.Clinical rheumatology · 2021Review
- The Search for Biomarkers in Fibromyalgia.Diagnostics (Basel, Switzerland) · 2021Review
- Assessing our approach to diagnosing Fibromyalgia.Expert review of molecular diagnostics · 2020Review
- Burden of Illness Due to Fibromyalgia in a Neurology Clinic.Journal of neurosciences in rural practice · 2020Article
- Article
- Rethinking the criteria for fibromyalgia in 2019: the ABC indicators.Journal of pain research · 2019Article
- Facts and myths pertaining to fibromyalgia.Dialogues in clinical neuroscience · 2018Review
- Article
- Impact of Electroacupuncture Treatment on Quality of Life and Heart Rate Variability in Fibromyalgia Patients.Journal of evidence-based complementary & alternative medicine · 2017Article
- A paradigm change to inform fibromyalgia research priorities by engaging patients and health care professionals.Canadian journal of pain = Revue canadienne de la douleur · 2017Article
- Fibromyalgia is associated to receiving chronic medications beyond appropriateness: a cross-sectional study.Rheumatology international · 2016Article
- [Fibromyalgia syndrome after comprehensive treatment of breast cancer: a case report].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 5 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives. Fibromyalgia syndrome (FMS), characterized by subjective complaints without physical or biomarker abnormality, courts controversy. Recommendations in recent guidelines addressing classification and diagnosis were examined for consistencies or differences. Methods. Systematic searches from January 2008 to February 2013 of the US-American National Guideline Clearing House, the Scottish Intercollegiate Guidelines Network, Guidelines International Network, and Medline for evidence-based guidelines for the management of FMS were conducted. Results. Three evidence-based interdisciplinary guidelines, independently developed in Canada, Germany, and Israel, recommended that FMS can be clinically diagnosed by a typical cluster of symptoms following a defined evaluation including history, physical examination, and selected laboratory tests, to exclude another somatic disease. Specialist referral is only recommended when some other physical or mental illness is reasonably suspected. The diagnosis can be based on the (modified) preliminary American College of Rheumatology (ACR) 2010 diagnostic criteria. Discussion. Guidelines from three continents showed remarkable consistency regarding the clinical concept of FMS, acknowledging that FMS is neither a distinct rheumatic nor mental disorder, but rather a cluster of symptoms, not explained by another somatic disease. While FMS remains an integral part of rheumatology, it is not an exclusive rheumatic condition and spans a broad range of medical disciplines.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.